Effects of pulsatile intravenous follicle-stimulating hormone treatment on ovarian function in women with obesity

Previous
Previous

Meeting the demand for fertility services: the present and future of reproductive endocrinology and infertility in the United States

Next
Next

An "iron-clad" link between obesity and accelerated depletion of the ovarian reserve